Natco Pharma share news, announcements and annual reports
NSE: NATCOPHARMBSE: 524816Pharmaceuticals & BiotechnologySmall Cap
Natco Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, Dec 1995 on NSE
Last close ₹794.55up ₹4.35 (0.55%)BSE ₹794.05
Share price at the NSE close on 27 Oct 2026. Previous close ₹790.20.
27 Oct: open ₹785.50, high ₹798.85, low ₹785.50
52-week range of traded prices to 27 Oct 2026
₹773.60Low, 22 Oct 2026₹1,226.80High, 12 May 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,587 Cr380th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.62
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.57%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,33,45962.5% delivered
Natco Pharma has 1,034 announcements on record, routine notices left out; 6 in the 30 days to 28 Oct 2026, the latest on 23 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Natco Pharma quarterly results
Aug14Fri
The board met on 14 Aug 2026 to consider financial results, dividend and fund raising
Notice filed 6 Aug 2026
Natco Pharma annual reports, presentations and earnings calls
The company's own documents, latest first.Natco Pharma financials, year by year
Annual reports17
- Annual report, year to Mar 20264 Sep 2026
- Annual report, year to Mar 202529 Aug 2025
- Annual report, year to Mar 20244 Sep 2024
- Annual report, year to Mar 20234 Sep 2023, a zip file
- Annual report, year to Mar 20222 Sep 2022, a zip file
12 earlier reports
- Annual report, year to Mar 20212 Sep 2021, a zip file
- Annual report, year to Mar 202018 Sep 2020, a zip file
- Annual report, year to Mar 20199 Aug 2019, a zip file
- Annual report, year to Mar 201818 Sep 2018, a zip file
- Annual report, year to Mar 20173 Oct 2017, a zip file
- Annual report, year to Mar 20161 Oct 2016, a zip file
- Annual report, year to Mar 20153 Sep 2015, a zip file
- Annual report, year to Mar 20146 Sep 2014, a zip file
- Annual report, year to Mar 20138 Oct 2013, a zip file
- Annual report, year to Mar 20121 Jan 2013, a zip file
- Annual report, year to Mar 20118 Sep 2011, a zip file
- Annual report, year to Mar 20103 Sep 2010, a zip file
Investor presentations45
- Investor Presentation19 Aug 2026
- Presentation14 Aug 2026
- FY26 Earnings Presentation29 May 2026
- Investor Presentation12 Feb 2026
- Presentation14 Nov 2025
40 earlier presentations
- Investor Presentation12 Aug 2025
- Investor Presentation23 Jul 2025
- Investor Presentation28 May 2025
- Investor Presentation12 Feb 2025
- Investor Presentation12 Nov 2024
- Investor Presentation12 Aug 2024
- Presentation29 May 2024
- Investor Presentation28 May 2024
- Investor Presentation15 Feb 2024
- Investor Presentation15 Nov 2023
- Investor Presentation10 Aug 2023
- Investor Presentation30 May 2023
- Investor Presentation9 Feb 2023
- Investor Presentation11 Nov 2022
- Investor Presentation for the Quarter ended 30th June, 202210 Aug 2022
- Investor Presentation for the Q4 FY227 Jun 2022
- Investor Presentation17 Feb 2022
- Investor Presentation15 Nov 2021
- Investor Presentation18 Aug 2021
- Investor Presentation12 Jul 2021
- Investor Presentation15 Feb 2021
- Investor Presentation for the quarter ended September 30, 202016 Nov 2020
- Investor Presentation for Quarter ended June 30, 202020 Aug 2020
- Investor Presentation for the quarter and year ended 31st March, 20203 Jul 2020
- Investor Presentation for the Q3 FY 2019-202015 Feb 2020
- Investor Presentation Q2 FY 2019-202015 Nov 2019
- Investor Presentation for the quarter ended June 30, 20199 Sep 2019
- Investor Presentation7 Jun 2019
- Investor Presentation18 Feb 2019
- Investor Presentation for the Q2 FY198 Nov 2018
- Investor Presentation9 Aug 2018, a zip file
- Investor Presentation for the FY 2017-18.26 May 2018, a zip file
- Investor Presentation7 Feb 2018, a zip file
- Investor Presentation4 Nov 2017, a zip file
- Investor Presentation14 Aug 2017, a zip file
- Investor Presentation3 Jun 2017, a zip file
- Investor Presentation16 Feb 2017, a zip file
- Investor Presentation22 Nov 2016, a zip file
- Investor Presentation for the quarter ended June 30, 2016.16 Sep 2016, a zip file
- Presentation made to analysts / Investors.3 Jun 2016, a zip file
Earnings calls40
- Transcript18 Aug 2026
- Link of Recording14 Aug 2026
- Transcript4 Jun 2026
- Link of Recording30 May 2026
- Transcript18 Feb 2026
35 earlier call documents
- Link of Recording for the Concall held on 12th February, 202612 Feb 2026
- Transcript20 Nov 2025
- Link of Recording15 Nov 2025
- Transcript19 Aug 2025
- Link of Recording13 Aug 2025
- Transcript29 Jul 2025
- Link of Recording24 Jul 2025
- Transcript4 Jun 2025
- Link of Recording29 May 2025
- Transcript19 Feb 2025
- Link of Recording13 Feb 2025
- Transcript21 Nov 2024
- Link of Recording13 Nov 2024
- Transcript21 Aug 2024
- Transcript21 Aug 2024
- Link of Recording13 Aug 2024
- Transcript4 Jun 2024
- Link of Recording of the earning call held on May 28, 202429 May 2024
- Transcript21 Feb 2024
- Link of Recording15 Feb 2024
- Transcript21 Nov 2023
- Link of Recording16 Nov 2023
- Transcript for the earnings call for the quarter ended June 30, 202314 Aug 2023
- Link of Audio Recording of the Q1FY2024 Concall10 Aug 2023
- Transcript1 Jun 2023
- Link of Recording30 May 2023
- Transcript13 Feb 2023
- Link of Recording10 Feb 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call held on 11th November, 202217 Nov 2022
- Audio Transcript for Q2 FY2023 Con call11 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call held on 10th August, 202216 Aug 2022
- Weblink of Recording of Analysts/Institutional Investor Meet/Con. Call held on 10th August, 202210 Aug 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call3 Jun 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call31 May 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call held on 31st May, 202231 May 2022
Natco Pharma share news and announcements
Newest first. Page 1 of 21.
Oct 2026
Sep 2026
28 Sep · Committee Meeting Updates
25 Sep · Corporate action
9 Sep · Corporate action
9 Sep · Board meeting
4 Sep · Board meeting
2 Sep · Analysts
Aug 2026
24 Aug · Analysts
19 Aug · Analysts
16 Aug · Analysts
14 Aug · Corporate action
11 Aug · Analysts
Jul 2026
14 Jul · Legal
8 Jul · Board meeting
Jun 2026
May 2026
21 May · Analysts
14 May · Legal
Apr 2026
Mar 2026
24 Mar · Board meeting
18 Mar · Board meeting
6 Mar · Analysts
Feb 2026
25 Feb · News Verification
The exchange asked on 24 Feb 2026
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 14 Aug 2026Resultsdown 5.10%−4.8 pts vs Nifty 500market median −0.7% · five sessions −7.8% (−7.2 pts vs Nifty 500) · volume 7.2× usual · delivery −30.1 pts against usual · The announcement
- 7 Jul 2026Board or managers changedup 5.60%+5.9 pts vs Nifty 500market median 0.0% · five sessions +5.1% (+5.5 pts vs Nifty 500) · volume 3.4× usual · delivery −14.3 pts against usual · The announcement
- 29 May 2026Resultsdown 13.60%−12.2 pts vs Nifty 500market median −0.7% · five sessions −21.9% (−19.8 pts vs Nifty 500) · volume 6.7× usual · delivery −14.2 pts against usual · The announcement
- 13 Feb 2026Resultsdown 1.91%−0.5 pts vs Nifty 500market median −0.7% · five sessions +5.8% (+7.3 pts vs Nifty 500) · volume 0.9× usual · delivery −2.3 pts against usual · The announcement
- 12 Feb 2026Dividenddown 1.29%−0.7 pts vs Nifty 500market median 0.0% · five sessions +4.7% (+5.2 pts vs Nifty 500) · volume 3.4× usual · delivery −22.6 pts against usual · The announcement
- 1 Dec 2025Credit ratingup 2.96%+3.0 pts vs Nifty 500market median 0.0% · five sessions +6.4% (+6.8 pts vs Nifty 500) · volume 2.3× usual · delivery −28.3 pts against usual · The announcement
- 14 Nov 2025Resultsdown 1.63%−1.7 pts vs Nifty 500market median −0.7% · five sessions +5.2% (+4.6 pts vs Nifty 500) · volume 2.4× usual · delivery −20.0 pts against usual · The announcement
- 1 Oct 2025Board or managers changedup 1.38%+0.5 pts vs Nifty 500market median 0.0% · five sessions +1.7% (0.0 pts vs Nifty 500) · volume 0.8× usual · delivery −8.3 pts against usual · The announcement
- 12 Aug 2025Resultsdown 1.28%−1.0 pts vs Nifty 500market median −0.7% · five sessions −0.8% (−2.7 pts vs Nifty 500) · volume 1.3× usual · delivery −14.8 pts against usual · The announcement
- 21 Jul 2025Board or managers changeddown 1.88%−2.3 pts vs Nifty 500market median 0.0% · five sessions −6.5% (−5.4 pts vs Nifty 500) · volume 0.5× usual · delivery +2.5 pts against usual · The announcement
20 earlier announcements
- 29 May 2025Resultsup 3.64%+3.3 pts vs Nifty 500market median −0.7% · five sessions −0.4% (−0.5 pts vs Nifty 500) · volume 6.8× usual · delivery −22.7 pts against usual · The announcement
- 29 May 2025Board or managers changedup 3.64%+3.3 pts vs Nifty 500market median 0.0% · five sessions −0.4% (−0.5 pts vs Nifty 500) · volume 6.8× usual · delivery −22.7 pts against usual · The announcement
- 28 Feb 2025Board or managers changeddown 3.27%−1.1 pts vs Nifty 500market median 0.0% · five sessions +3.3% (+2.6 pts vs Nifty 500) · volume 1.0× usual · delivery +11.7 pts against usual · The announcement
- 14 Nov 2024Dividendup 0.70%+0.5 pts vs Nifty 500market median 0.0% · five sessions −0.7% (−2.1 pts vs Nifty 500) · volume 2.3× usual · delivery −6.1 pts against usual · The announcement
- 12 Nov 2024Dividenddown 0.32%+0.8 pts vs Nifty 500market median 0.0% · five sessions −2.2% (+0.4 pts vs Nifty 500) · volume 5.8× usual · delivery −24.6 pts against usual · The announcement
- 25 Sep 2024Board or managers changedup 0.15%+0.2 pts vs Nifty 500market median 0.0% · five sessions −1.0% (−0.5 pts vs Nifty 500) · volume 0.8× usual · delivery −0.7 pts against usual · The announcement
- 12 Aug 2024Dividendup 3.76%+3.8 pts vs Nifty 500market median 0.0% · five sessions +1.2% (+0.3 pts vs Nifty 500) · volume 4.1× usual · delivery −16.7 pts against usual · The announcement
- 29 Jul 2024Board or managers changedup 0.91%+0.5 pts vs Nifty 500market median 0.0% · five sessions +2.5% (+2.6 pts vs Nifty 500) · volume 1.1× usual · delivery −5.4 pts against usual · The announcement
- 13 Jun 2024Board or managers changedup 0.65%+0.1 pts vs Nifty 500market median 0.0% · five sessions +0.5% (−1.1 pts vs Nifty 500) · volume 0.5× usual · delivery −2.3 pts against usual · The announcement
- 1 Mar 2024Board or managers changeddown 1.24%−2.5 pts vs Nifty 500market median 0.0% · five sessions +2.5% (+1.1 pts vs Nifty 500) · volume 0.3× usual · delivery +8.9 pts against usual · The announcement
- 14 Feb 2024Dividendup 3.26%+2.6 pts vs Nifty 500market median 0.0% · five sessions +21.5% (+19.0 pts vs Nifty 500) · volume 5.9× usual · delivery −27.0 pts against usual · The announcement
- 28 Dec 2023Board or managers changedup 0.17%−0.4 pts vs Nifty 500market median 0.0% · five sessions +4.2% (+3.8 pts vs Nifty 500) · volume 0.8× usual · delivery −8.0 pts against usual · The announcement
- 15 Nov 2023Dividenddown 4.48%−5.6 pts vs Nifty 500market median 0.0% · five sessions −1.9% (−3.6 pts vs Nifty 500) · volume 4.2× usual · delivery −14.6 pts against usual · The announcement
- 15 Nov 2023Board or managers changeddown 4.48%−5.6 pts vs Nifty 500market median 0.0% · five sessions −1.9% (−3.6 pts vs Nifty 500) · volume 4.2× usual · delivery −14.6 pts against usual · The announcement
- 9 Aug 2023Dividendup 2.03%+1.7 pts vs Nifty 500market median 0.0% · five sessions −5.1% (−4.5 pts vs Nifty 500) · volume 3.7× usual · delivery +0.5 pts against usual · The announcement
- 29 May 2023Resultsup 0.52%0.0 pts vs Nifty 500market median −0.7% · five sessions −0.3% (−1.0 pts vs Nifty 500) · volume 4.1× usual · delivery −32.2 pts against usual · The announcement
- 16 May 2023Buybackdown 0.83%−0.5 pts vs Nifty 500market median 0.0% · five sessions −1.7% (−1.4 pts vs Nifty 500) · volume 0.4× usual · delivery −25.5 pts against usual · The announcement
- 15 May 2023Buybackup 1.12%+0.7 pts vs Nifty 500market median 0.0% · five sessions −0.9% (−0.4 pts vs Nifty 500) · volume 0.4× usual · delivery −15.1 pts against usual · The announcement
- 10 Mar 2023Buybackdown 1.12%−0.3 pts vs Nifty 500market median 0.0% · five sessions −6.6% (−3.4 pts vs Nifty 500) · volume 0.8× usual · delivery −3.8 pts against usual · The announcement
- 9 Mar 2023Buybackdown 1.40%−0.6 pts vs Nifty 500market median 0.0% · five sessions −6.1% (−2.1 pts vs Nifty 500) · volume 1.6× usual · delivery +18.2 pts against usual · The announcement
Natco Pharma results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.